Medgenics Company Profile (NYSEMKT:MDGN)

Analyst Ratings

Consensus Ratings for Medgenics (NYSEMKT:MDGN) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.50

Analysts' Ratings History for Medgenics (NYSEMKT:MDGN)
Show:
DateFirmActionRatingPrice TargetActions
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$15.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2015Needham & Company LLCInitiated CoverageBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2015Piper Jaffray Cos.Boost Price TargetBuy$7.00 -> $11.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Medgenics (NYSEMKT:MDGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/10/2016Q116($0.26)($0.34)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2016Q415($0.28)($0.20)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q315($0.31)($0.33)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.34)($0.28)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/17/2015Q115($0.34)($0.36)$2.14 million$3.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2015Q414($0.22)($0.30)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/15/2014Q3($0.25)($0.21)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/16/2014Q214($0.23)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Medgenics (NYSEMKT:MDGN)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Medgenics (NYSEMKT:MDGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Medgenics (NYSEMKT:MDGN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
10/6/2015Joseph J Grano JrDirectorBuy15,384$6.50$99,996.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2015Michael F ColaCEOBuy38,460$6.50$249,990.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/21/2015Isaac BlechDirectorSell94,825$9.96$944,457.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2015Eugene A BauerDirectorSell50,000$8.45$422,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015Sol J BarerDirectorBuy150,000$7.44$1,116,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Alastair J T ClemowDirectorBuy12,195$4.10$49,999.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Michael F ColaCEOBuy60,976$4.10$250,001.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Scott ApplebaumInsiderBuy6,098$4.10$25,001.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2014Sol J BarerDirectorBuy28,000$7.96$222,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Sol J BarerDirectorBuy60,000$6.91$414,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2014Andrew PearlmanDirectorSell20,000$8.00$160,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/30/2014Andrew PearlmanDirectorSell25,000$7.50$187,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Andrew PearlmanDirectorSell80,000$6.60$528,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2013Alastair J T ClemowDirectorBuy4,500$5.78$26,010.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/13/2013Sol J BarerDirectorBuy20,000$5.37$107,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/6/2013Clarence L DellioCOOSell2,000$6.50$13,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2013Eugene A BauerDirectorSell20,000$6.30$126,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2013Sol J BarerDirectorBuy20,000$6.59$131,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2013Sol J BarerDirectorBuy25,000$6.80$170,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013Sol J BarerDirectorBuy20,000$6.50$130,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2013Sol J BarerDirectorBuy20,000$5.57$111,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013Clarence L DellioCOOBuy1,000$4.14$4,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Medgenics (NYSEMKT:MDGN)
DateHeadline
06/22/16 08:55 AM$20M stock sale: Gene therapy company raising funds for rare disease treatments -
06/21/16 04:46 PMWhy Medgenics Inc.'s Shares Are Down Big Today
06/21/16 09:36 AMPre-Open Stock Movers 06/21: (ROSG) (CDXC) (OPK) Higher; (SCYX) (WERN) (SWFT) Lower (more...)
06/21/16 09:36 AMMedgenics (MDGN) Plans Common Stock Offering
06/21/16 08:29 AMMedgenics Announces Pricing of Public Offering of Common Stock - [at noodls] - PHILADELPHIA, PA -- (Marketwired) -- 06/21/16 -- Medgenics, Inc.(NYSE MKT: MDGN) today announced the pricing of 3,640,000 shares of its common stock in a previously announced underwritten public offering ...
06/20/16 03:19 PMMedgenics Announces Public Offering of Common Stock - [at noodls] - PHILADELPHIA, PA -- (Marketwired) -- 06/20/16 -- Medgenics, Inc.(NYSE: MDGN), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell shares of its common stock in an ...
06/17/16 03:31 PMMEDGENICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure -
06/17/16 07:29 AMMedgenics Announces Enrollment of First Patient in Phase 2/3 Clinical Trial of NFC-1 in Adolescents With mGluR Mutation Positive ADHD - [at noodls] - PHILADELPHIA, PA -- (Marketwired) -- 06/17/16 -- Medgenics, Inc.(NYSE: MDGN) today announced the enrollment of the first patient into the SAGA (Study of Adolescent Glutamate Receptor Network Copy Number ...
06/07/16 03:30 PMMDGN Adds Another High-Potential Orphan Candidate -
06/06/16 01:28 PMMedgenics, Inc. :MDGN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 -
06/06/16 10:10 AMMedgenics, CHOP & Japanese biopharm firm team up to take on rare pediatric disease -
06/06/16 06:08 AMMedgenics Obtains Rights to First-in-Class Biologic for Severe Pediatric Onset IBD - [at noodls] - PHILADELPHIA, PA -- (Marketwired) -- 06/06/16 -- (NYSE MKT: MDGN) Collaboration with Kyowa Hakko Kirin to develop anti-LIGHT monoclonal antibody Second program from research collaboration with The Children's ...
06/06/16 06:02 AMMEDGENICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits -
06/06/16 06:02 AM7:02 am Medgenics enters collaboration with Kyowa Hakko Kirin for the development and commercialization of its anti-LIGHT monoclonal antibody -
06/01/16 07:53 AMMedgenics to Present at the Jefferies 2016 Global Healthcare Conference - [at noodls] - PHILADELPHIA, PA -- (Marketwired) -- 06/01/16 -- Medgenics, Inc. (NYSE MKT: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the Jefferies 2016 Global ...
05/21/16 12:38 PMRevenue Update on Medgenics Inc(NYSEMKT:MDGN) - Trade Calls - Revenue Update on Medgenics Inc(NYSEMKT:MDGN)Trade CallsMedgenics Inc(NYSEMKT:MDGN) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 10, 2016. Earnings per share were $-0.34. Analysts had estimated an EPS of $-0.26. In a different note, On Mar 9, ...
05/18/16 01:22 PMMedgenics Inc (NYSEMKT:MDGN) Stock Price Up as Sentiment Increases - Wall Street Hints and News - Medgenics Inc (NYSEMKT:MDGN) Stock Price Up as Sentiment IncreasesWall Street Hints and NewsMedgenics Inc (NYSEMKT:MDGN) institutional sentiment increased to 2.69 in Q4 2015. Its up 1.08, from 1.61 in 2015Q3. The ratio increased, as 35 institutional investors opened new or increased holdings, while 13 reduced and sold their equity positions ...
05/10/16 06:58 AMStock Highlights: Medgenics, Inc. (NYSEMKT:MDGN), Summer Infant, Inc. (NASDAQ:SUMR), Potlatch Corporation ... - KC Register - Stock Highlights: Medgenics, Inc. (NYSEMKT:MDGN), Summer Infant, Inc. (NASDAQ:SUMR), Potlatch Corporation ...KC RegisterMedgenics, Inc. (NYSEMKT:MDGN) said that, it will host a conference call and live audio webcast on Tuesday, May 10, 2016 at 8:30 a.m. EDT to discuss the financial results for the first quarter ended March 31, 2016. On Friday Medgenics, Inc.
05/10/16 06:07 AMQ1 2016 Medgenics Inc Earnings Release - Before Market Open -
05/09/16 06:58 AMNext Weeks Broker Price Targets For Medgenics, Inc. (MDGN) - Share Trading News - Next Weeks Broker Price Targets For Medgenics, Inc. (MDGN)Share Trading NewsMedgenics, Inc. has a 50 day moving average of 4.75 and a 200 day moving average of 5.22. The stock's market capitalization is 153.78M, it has a 52-week low of 3.09 and a 52-week high of 10.25. The share price of the company (MDGN) was up +1.52%, ...
05/07/16 06:43 AMMedgenics Incorporated (NYSEMKT:MDGN) Sellers Covered 1.1% of Their Shorts - B.O.D.Y Confidential - Medgenics Incorporated (NYSEMKT:MDGN) Sellers Covered 1.1% of Their ShortsB.O.D.Y ConfidentialThe short interest to Medgenics Incorporated's float is 5.79%. The stock increased 1.52% or $0.07 on May 6, hitting $4.68. About 114,680 shares traded hands or 36.94% up from the average. Medgenics Inc (NYSEMKT:MDGN) has declined 28.66% since ...and more »
05/02/16 06:57 AMTop Stories: Medgenics (NYSEMKT:MDGN), Cellectar Biosciences (NASDAQ:CLRB), Royal Caribbean Cruises Ltd ... - KC Register - Top Stories: Medgenics (NYSEMKT:MDGN), Cellectar Biosciences (NASDAQ:CLRB), Royal Caribbean Cruises Ltd ...KC RegisterMedgenics, Inc. (NYSEMKT:MDGN) announced the appointment of Eric Phillips, MPH, ScD as Vice President of Regulatory Affairs. In this role, Dr. Phillips will be a key member of the Medgenics leadership team setting the strategy and tactics for all ...
05/02/16 06:57 AMBroker Outlook For The Week Ahead: Medgenics, Inc. (MDGN) - Share Trading News - Broker Outlook For The Week Ahead: Medgenics, Inc. (MDGN)Share Trading NewsThey now have a USD 11.5 price target on the stock. The share price of Medgenics, Inc. (MDGN) was down -6.47% during the last trading session, with a day high of 5.17. 93683 shares were traded on Medgenics, Inc.'s last session. The stock's 50 day ...Medgenics Incorporated (NYSEMKT:MDGN) Short Interest Decreased By 1.1%The Postall 2 news articles »
04/29/16 07:36 AMMedgenics, Inc. (MDGN) Updated Broker Price Targets - Share Trading News - Medgenics, Inc. (MDGN) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Medgenics, Inc. (MDGN). The latest reports which are currently in issue on Thursday 28th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
04/27/16 08:13 AMNew Analyst Ratings On Medgenics, Inc. (MDGN) - Risers & Fallers - New Analyst Ratings On Medgenics, Inc. (MDGN)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Medgenics, Inc. (MDGN). The latest broker reports which are currently outstanding on Tuesday 26th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...
04/23/16 07:15 AMUpgrades And Downgrades For Medgenics, Inc. (MDGN) - Risers & Fallers - Upgrades And Downgrades For Medgenics, Inc. (MDGN)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Medgenics, Inc. (MDGN). The latest broker reports which are currently outstanding on Friday 22nd of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, ...
04/20/16 07:21 AMMedgenics Hires Eric Phillips, MPH, ScD as Vice President of Regulatory Affairs - [at noodls] - PHILADELPHIA, PA -- (Marketwired) -- 04/20/16 -- Medgenics, Inc. (NYSE MKT: MDGN) today announced the appointment of Eric Phillips, MPH, ScD as Vice President of Regulatory Affairs. In this role, Dr. Phillips ...
04/19/16 08:18 AMMedgenics Incorporated (NYSEMKT:MDGN) Shorts Decreased by 0.69% After Short Covering - RiversideGazette.com - Medgenics Incorporated (NYSEMKT:MDGN) Shorts Decreased by 0.69% After Short CoveringRiversideGazette.comThe short interest to Medgenics Incorporated's float is 5.85%. The stock increased 3.73% or $0.18 during the last trading session, hitting $5.01. About 77,997 shares traded hands. Medgenics Inc (NYSEMKT:MDGN) has declined 35.02% since September 11, ...and more »
04/15/16 11:01 AMLatest Analyst Ratings For Medgenics, Inc. (MDGN) - Share Trading News - Latest Analyst Ratings For Medgenics, Inc. (MDGN)Share Trading NewsMedgenics, Inc. has a 50 day moving average of 4.42 and a 200 day moving average of 5.48. The stock's market capitalization is 158.39M, it has a 52-week low of 3.09 and a 52-week high of 10.25. The share price of the company (MDGN) was down -1.43%, ...
04/14/16 12:22 PMMedgenics Inc (NYSEMKT:MDGN) Institutional Investors Sentiment Change - RiversideGazette.com - Medgenics Inc (NYSEMKT:MDGN) Institutional Investors Sentiment ChangeRiversideGazette.comMedgenics Inc (NYSEMKT:MDGN) institutional sentiment increased to 2.69 in 2015 Q3. Its up 1.08, from 1.61 in 2015Q2. The ratio is more positive, as 29 investment professionals started new and increased holdings, while 18 sold and trimmed equity ...Earnings Per Share for Medgenics Inc (MDGN) Expected to DecreaseStock Callerall 2 news articles »
04/13/16 01:08 PMShort Interest in Medgenics Inc (MDGN) Decreases By 0.7% - Washington News Wire - Washington News WireShort Interest in Medgenics Inc (MDGN) Decreases By 0.7%Washington News WireMedgenics logo Medgenics Inc (NYSE:MDGN) was the target of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 1,477,162 shares, a drop of 0.7% from the March 15th total of 1,487,422 shares, ...Broker Roundup For Medgenics, Inc. (MDGN)Share Trading NewsMedgenics, Inc. (MDGN) Latest Broker CoverageRisers & FallersMedgenics Incorporated (NYSEMKT:MDGN) Shorts Decreased by 3.43% After Short CoveringRiversideGazette.comall 5 news articles »
04/11/16 01:54 PMMedgenics, Inc. (MDGN) Latest Broker Coverage - Risers & Fallers - Medgenics, Inc. (MDGN) Latest Broker CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of Medgenics, Inc. (MDGN). According to the latest broker reports outstanding on Monday 11th of April, 0 analysts have a rating of “strong buy”, 4 analysts “buy”, 0 ...
04/09/16 10:22 AMDoes Medgenics Inc Have Any Gas After Today's Huge Decline? - Business Standard Tribune - Does Medgenics Inc Have Any Gas After Today's Huge Decline?Business Standard TribuneThe stock of Medgenics Inc (NYSEMKT:MDGN) is a huge mover today! The stock decreased 3.88% or $0.19 on April 8, hitting $4.71. About 70,508 shares traded hands. Medgenics Inc (NYSEMKT:MDGN) has declined 37.62% since September 2, 2015 and is ...
04/07/16 11:30 AMMedgenics Inc (NYSEMKT:MDGN)'s Company Shares Increased 14.11% After High Volatility - Clinton Financial - Medgenics Inc (NYSEMKT:MDGN)'s Company Shares Increased 14.11% After High VolatilityClinton FinancialThe shares of Medgenics Inc (NYSEMKT:MDGN) increased by 14.11% in the last 20 days and rose 8.22% in the past 5 trading sessions. Medgenics Inc (NYSEMKT:MDGN) shares opened at $4.55 in the last session and had intraday high of $4.78 and low of ...
04/07/16 11:30 AMBroker Roundup For Medgenics, Inc. (MDGN) - Share Trading News - Broker Roundup For Medgenics, Inc. (MDGN)Share Trading NewsRecently some investment brokers have made changes to their outstanding price targets on shares of Medgenics, Inc. (MDGN). According to data from Reuters, 0 analysts have a rating of “buy”, 4 analysts “outperform”, 0 analysts “hold”, 0 analysts ...
04/05/16 12:31 PMQvt Financial Lp buys $3.9 Million stake in Medgenics Inc (MDGN) - Street Edition - Qvt Financial Lp buys $3.9 Million stake in Medgenics Inc (MDGN)Street EditionMedgenics Inc (MDGN) : Qvt Financial Lp scooped up 600,000 additional shares in Medgenics Inc during the Q4 period, according to a recent disclosure to the SEC. The investment management firm now holds a total of 867,608 shares of Medgenics Inc ...After Last Week What Do Analysts Think Of Medgenics, Inc. (MDGN)Share Trading NewsMEDGENICS INC (NYSE:MDGN) rated an average of Strong Buy by 4 of analystsHints News NetworkMedgenics Incorporated (NYSEMKT:MDGN) Shorts Decreased by 3.43% After Short CoveringSmallCapWired.comall 7 news articles »
04/03/16 12:31 PMAfter Last Week What Do Analysts Think Of Medgenics, Inc. (MDGN) - Share Trading News - After Last Week What Do Analysts Think Of Medgenics, Inc. (MDGN)Share Trading NewsRecently some investment brokers have made changes to their outstanding price targets on shares of Medgenics, Inc. (MDGN). According to data from Reuters, 0 analysts have a rating of “buy”, 4 analysts “outperform”, 0 analysts “hold”, 0 analysts ...
04/01/16 12:52 PMMEDGENICS INC (NYSE:MDGN): Analysts Maintain an average rating of Strong Buy - Hints News Network - MEDGENICS INC (NYSE:MDGN): Analysts Maintain an average rating of Strong BuyHints News NetworkMEDGENICS INC (NYSE:MDGN) has been been rated on average a “Strong Buy” from the 4 equities analysts that maintain coverage on the company. Based on the data, 0 firm rates the company a 'hold', 0 rates a 'sell' and 4 have issued a 'buy' rating for the ...and more »
03/31/16 01:19 PMNew Broker Ratings For Medgenics, Inc. (MDGN) - FTSE News - New Broker Ratings For Medgenics, Inc. (MDGN)FTSE News01/20/2015 – Medgenics, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 11.5 price target on the stock. The share price of Medgenics, Inc. (MDGN) was down -0.75% during the last trading session, with a day ...
03/30/16 12:15 PMMedgenics Incorporated (NYSEMKT:MDGN) Sellers Covered 3.43% of Their Shorts - Stock Caller - Medgenics Incorporated (NYSEMKT:MDGN) Sellers Covered 3.43% of Their ShortsStock CallerThe short interest to Medgenics Incorporated's float is 5.9%. The stock increased 4.69% or $0.2 during the last trading session, hitting $4.46. Medgenics Inc (NYSEMKT:MDGN) has declined 40.85% since August 21, 2015 and is downtrending.
03/30/16 12:15 PMOpaleye Management buys $6.3 Million stake in Medgenics Inc (MDGN) - Los Angeles Mirror - Opaleye Management buys $6.3 Million stake in Medgenics Inc (MDGN)Los Angeles MirrorMedgenics Inc (MDGN) : Opaleye Management scooped up 331,600 additional shares in Medgenics Inc during the Q4 period, according to a recent disclosure to the SEC. The investment management firm now holds a total of 1,390,000 shares of Medgenics ...
03/25/16 01:07 PMMedgenics, Inc. (MDGN) New Analyst Updates - Risers & Fallers - Medgenics, Inc. (MDGN) New Analyst UpdatesRisers & FallersA number of investment brokers have recently updated their price targets on shares of Medgenics, Inc. (MDGN). According to the latest broker reports outstanding on Friday 25th of March, 0 analysts have a rating of “strong buy”, 4 analysts “buy”, 0 ...
03/24/16 01:49 PMMedgenics, Inc. (MDGN) New Analyst Ratings - Share Trading News - Medgenics, Inc. (MDGN) New Analyst RatingsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Medgenics, Inc. (MDGN). The latest reports which are currently in issue on Thursday 24th of March state 0 analysts have a rating of “strong buy”, 4 analysts “buy”, 0 ...Medgenics Incorporated (NYSEMKT:MDGN) Shorted Shares Increased By 5.03%Business Standard Tribuneall 2 news articles »
03/20/16 12:48 PMMedgenics Incorporated (NYSEMKT:MDGN) Sellers Increased By 5.03% Their Shorts - Business Standard Tribune - Medgenics Incorporated (NYSEMKT:MDGN) Sellers Increased By 5.03% Their ShortsBusiness Standard TribuneThe short interest to Medgenics Incorporated's float is 6.1%. The stock increased 10.17% or $0.42 on March 18, hitting $4.55. About 175,133 shares traded hands or 76.44% up from the average. Medgenics Inc (NYSEMKT:MDGN) has declined 44.24% since ...
03/19/16 10:49 AMAnalysts Release New Consensus Estimates for MEDGENICS INC (NYSE:MDGN) - Hints News Network - Analysts Release New Consensus Estimates for MEDGENICS INC (NYSE:MDGN)Hints News NetworkMEDGENICS INC (NYSE:MDGN) has been been rated on average a “Strong Buy” from the 4 equities analysts that maintain coverage on the company. Based on the data, 0 firm rates the company a 'hold', 0 rates a 'sell' and 4 have issued a 'buy' rating for the ...
03/17/16 11:55 AMMedgenics Incorporated (NYSEMKT:MDGN) Shorted Shares Increased By 5.03% - RiversideGazette.com - Medgenics Incorporated (NYSEMKT:MDGN) Shorted Shares Increased By 5.03%RiversideGazette.comThe short interest to Medgenics Incorporated's float is 6.1%. The stock decreased 8.08% or $0.35 during the last trading session, hitting $3.98. Medgenics Inc (NYSEMKT:MDGN) has declined 49.75% since August 10, 2015 and is downtrending.Could Medgenics Inc See a Reversal After This Very Weak Session?SmallCapWired.comall 3 news articles »
03/17/16 11:55 AMMedgenics, Inc. (MDGN) Updated Price Targets - Share Trading News - Medgenics, Inc. (MDGN) Updated Price TargetsShare Trading NewsRecently analysts working for a variety of stock market brokerages have changed their consensus ratings and price targets on shares of Medgenics, Inc. (MDGN). The most recent broker reports which have been released note that 0 analysts have a rating of ...
03/15/16 10:42 AMMedgenics, Inc. (MDGN) Broker Updates - Risers & Fallers - Medgenics, Inc. (MDGN) Broker UpdatesRisers & FallersA number of investment brokers have recently updated their price targets on shares of Medgenics, Inc. (MDGN). According to the latest broker reports outstanding on Monday 14th of March, 0 analysts have a rating of “strong buy”, 4 analysts “buy”, 0 ...Institutional Investors Are Buying Medgenics Inc (NYSEMKT:MDGN)RiversideGazette.comall 2 news articles »
03/14/16 05:45 AMAnalysts maintain 12.8 on Medgenics Inc. Common Stock (AMEX:MDGN) - Hints News Network - Analysts maintain 12.8 on Medgenics Inc. Common Stock (AMEX:MDGN)Hints News NetworkMedgenics Inc. Common Stock (AMEX:MDGN) has been been rated on average a “Strong Buy” from the 4 equities analysts that maintain coverage on the company. Based on the data, 0 firm rates the company a 'hold', 0 rates a 'sell' and 4 have issued a 'buy' ...
03/11/16 01:28 PMInterview with the CFO: Medgenics Inc. (NYSEMKT:MDGN) - The Wall Street Transcript - Interview with the CFO: Medgenics Inc. (NYSEMKT:MDGN)The Wall Street TranscriptBrian Piper is Chief Financial Officer of Medgenics Inc. Mr. Piper was named Chief Financial Officer in February 2016 after joining Medgenics as VP, Finance and Investor Relations in April 2014. Prior to joining Medgenics, Mr. Piper served as Senior ...

Social

About Medgenics

Medgenics logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: MDGN
  • CUSIP:
Key Metrics:
  • Previous Close: $6.14
  • 50 Day Moving Average: $5.88
  • 200 Day Moving Average: $4.82
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $203.91M
  • Beta: 0.6
  • Current Year EPS Consensus Estimate: $-1.26 EPS
  • Next Year EPS Consensus Estimate: $-1.17 EPS
Additional Links: